Magazine
Sign up for your free subscription and keep up-to-date.
Upcoming Events
Newsletters
Stay updated on the latest news and technologies with Bioscienceworld's newsletters.
Five to choose from.
Best Practices
|
May 04 2007
MIHR and PIPRA to launch handbook of best practices for intellectual property management The Centre for the Management of Intellectual Property in Health Research & Development (MIHR) and the Public Intellectual Property Resource for Agriculture (PIPRA) formally launch the results of its recent and intensive collaboration: Intellectual Property Management in Health and Agricultural Innovation: A Handbook of Best Practices at this week's Bio International Convention, held in Boston.
|
|
March 12 2007
How To Get The Money Flowing From A VC For many biotechnology start-ups, venture capital investment is the lifeblood that sustains the company through the early years of product and patent portfolio development.
|
|
February 01 2007
Asked & Answered By Dave Howlett Dave Howlett is VP corporate development in Life Sciences at the MAGNES Group in Oakville, ON. He has presented his signature lecture series 'Knocking down Silos' to numerous companies, associations and universities in the biotech sector. Please see www.davehowlett.com for more information.
|
|
January 10 2007
Pathology Service Enhancement By Brian A. Schaefer, D. Phil Moving Expertise from the Laboratory to the Point of Care Throughout the last decade Drs. Smith and McNeely have conducted research aimed at improving clinical laboratory utilisation. This research has produced a technology that has been shown to have dramatic implications for clinical laboratories, patient care and healthcare economics. |
|
November 27 2006
Study finds standard resection performed over surgery A study of 8,380 patients from the Surveillance, Epidemiology and End Results registry has found that only one-third of patients who underwent surgical resection for locally advanced colorectal cancer received a multivisceral resection, a procedure recommended by the National Cancer Institute and American Society of Colon and Rectal Surgeons.
|
|
November 27 2006
New radiation technique reduces breast skin burns A new study demonstrates that delivering better radiation technique through breast intensity modulated radiation therapy (BIMRT) improves treatment tolerance and quality of life for patients.
|
|
November 27 2006
Miraculins targets gastric cancer test Miraculins Inc. has begun verifying gastric cancer biomarkers identified in an earlier discovery phase study in the hopes of finding a simple blood-based test for gastric cancer.
|
|
November 07 2006
Gowlings releases essential guide to life sciences law in Canada Gowling Lafleur Henderson LLP (Gowlings) and publisher Thomson Carswell have released Life Sciences Law in Canada, the first comprehensive guide to complex Canadian life sciences laws.
|
|
November 02 2006
Ecopia BioSciences Inc. has received a No Objection Letter Ecopia BioSciences Inc. has received a No Objection Letter from the Therapeutics Products Directorate of Health Canada.
|
|
October 24 2006
A shot in the arm for VIDO The federal government is putting $1.75 million into the University of Saskatchewans Vaccine and Infectious Disease Organization (VIDO), three years worth of funding dedicated to developing alternatives to antibiotics.
|
|
October 24 2006
Canadian Companies Dominate North Americas Technology Industry Canada is home to fully half of the top 10 technology firms on the continent, with growth that is more than double that of their American counterparts, according to ranking and highest revenue growth in North America according to the 2006 roundup of fastest growing assembled by Deloitte.
|
|
October 24 2006
Attitude affects womens math performance University of British Columbia researchers have explored the question of how a perception of genetic causes for womens ability to do mathematics can influence how well women do on mathematical tests
|
|
October 02 2006
Program Connects Students to Biotech A Manitoba program that connects teachers and students to the science of biotechnology has received a $150,000 US grant from the Monsanto Fund.
|
|
October 02 2006
Toxin Alert Receives U.S. Government Support The University of Southern Mississippi received a $1-million US award from the National Oceanographic and Atmospheric Administration to begin commercialization of Toxin Alert Inc.'s Toxin Guard biosensor system in Mississippi.
|
|
September 13 2006
Sigma, Oxford Sue Open Biosystems Sigma-Aldrich Corp. and Oxford BioMedica, a spinoff from Oxford University, have filed a lawsuit against Open Biosystems Inc.
|
|
September 12 2006
Miraculins Expands Pipeline Winnipeg-based Miraculins Inc. is planning on expanding its product pipeline to include new diagnostic research programs for pancreatic and stomach cancer.
|
|
September 11 2006
Theralase Builds Sports Specialty Theralase Technologies Inc. has named Dr. James R. Andrews as chairman of its newly organized medical and scientific advisory board.
|
|
September 11 2006
Cost-CuttingMeasuresAtMedMira Halifax-based MedMira Inc. is implementing cost-containment initiatives intended to reduce operating expenses by 33 per cent.
|
|
September 11 2006
You Can't Win Them All Making everyone happy with Bill 102 is proving tricky for the Ontario government, despite the widespread feeling that something needs to be done to fix the current system.
|
|
September 08 2006
Court Rules Against Biovail Patent A California judge has ruled that Anchen Pharmaceutical Inc.'s planned generic version of Wellbutrin XL® does not infringe on Biovail Corp.'s patent.
|
|
September 08 2006
Ontario Program Address Critical Startup Needs The Ontario government has launched its Market Readiness Program, part of the $160-million Ideas to Market strategy announced in the 2006 budget.
|
|
August 10 2006
MDX Changes Name to Reflect Core Business Vancouver-based MDX Medical Inc. has a new name. In June, the company change its moniker to Urodynamix Technologies Ltd. to reflect its focus on urology, bladder diagnostics and monitoring solutions.
|
|
August 10 2006
Delegates at GoldenHorseshoe Biosciences Summit Catch The Future The coming life sciences revolution will reinvent health care, cause some national economies to boom and others to shrivel, and even change how factories look and operate, said keynote speaker Juan Enriquez, founding director of Harvard Business Schools (Boston, MA) Life Sciences Project.
|
|
August 08 2006
Millenium Biologics Restructures, Cuts Staff Kingston, Ont.-based Millenium Biologix Corp. has announced updates on product milestones and staff layoffs in an effort to reduce costs.
|
|
July 17 2006
Arius Moves Up at TSX Toronto-based Arius Research Inc. has graduated from the Toronto Venture Exchange to the Toronto Stock Exchange (TSX) (Toronto, ON).
|
|
July 05 2006
Medical Ventures Establishes U.S. Sales Force Medical Ventures Corp. (Richmond, BC) will be establishing a seven-person sales team by the second quarter of this year to market its Metricath® technology in the United States.
|
|
July 05 2006
Viron Raises $20M Viron Therapeutics Inc. (London, ON) has closed a $20-million US Series A round of financing.
|
|
June 19 2006
MDS Receives Top CRO Honours MDS Pharma Services (St. Laurent, QC), a division of MDS Inc., has earned the honour of top CRO in Europe through a survey conducted by Thomas CentreWatch, a news and information service focused on the clinical research industry.
|
|
May 31 2006
Mercuriades Awards Presented The Quebec Federation of Chambers of Commerce recently presented its 2006 Mercuriades Awards honouring Quebec-based private companies and organizations.
|
|
April 10 2006
Roche Plans $10M Expansion Laval, Que.-based Roche Diagnostics will be doubling its current head office by constructing a 26,230 square foot building.
|
|
March 22 2006
Lawsuit Settled, PCR and Thermal Cycler Sales Resume F. Hoffman-La Roche Ltd.'s (Basel, Switzerland) Molecular Diagnostics division and Applied Biosystems (Foster City, CA) have settled lawsuits originally filed against MJ Research, which was later acquired by Bio-Rad Laboratories Inc. (Hercules, CA).
|
|
March 22 2006
Applied Biosystems Expands Service Program Eleven companies and academic centres have joined Applied Biosystems' (Foster City, CA) Advanced Gene Expression Service Provider Program, expanding its reach throughout North America, Europe and Asia.
|
|
March 02 2006
BioAlberta Honours Companies Alberta's non-profit bio-industry association, BioAlberta, recently announced the winners of its 2005 BioAlberta Achievement Awards.
|
|
March 02 2006
MedMira Launches Diagnostic Division MedMira Inc. (Halifax, NS) has launched a new division that will focus on developing new diagnostic instruments.
|
|
February 06 2006
Nexia to Refocus on Oil and Gas Industry Montreal-based Nexia Biotechnologies Inc. has announced its intention to reorganize into an oil and gas company upon completion of an assessment of its corporate assets.
|
|
September 13 2005
Top 10 Attributes of the Emerging Biotech Superstar By Helga Long With the dearth of drug approvals in recent years, venture capital companies, big pharma firms and major biotech customers are all competing to create those biotech firms that can develop the drugs of the future.
|
|
September 13 2005
Canadian Biotech Companies: When and Where to Go Public By Cheryl Reicin and Daniel Miller Biotech companies have an insatiable need for cash. This means that, at some point, every biotech company considers whether or not to go public, and the thin venture capital market in Canada propels Canadian biotechs to consider this decision earlier than their U.S. counterparts.
|
|
August 08 2005
Balancing Act By Amber Lepage-Monette Complementary talents allow co-founders Donald McCaffrey and Dr. Norman Wong to walk the tight rope of transitioning Resverlogix into a new company
|
|
May 10 2005
Market Access Planning for Emerging Medical Technology: Health Technology Assessments By Jacqueline Csonka-Peeren Medical device manufacturers looking to commercialize emerging medical technology need to consider not only strategies for intellectual property protection and regulatory approval, but also for technology diffusion, or market access.
|
|
May 10 2005
The VC Vista Compiled by Deborah Komlos Industry Views on Canadian Biotech Financings for 2005-06
|
|
March 07 2005
Cost-saving Patent Strategies for Small and New Companies By Jennifer Jannuska and Lenni Carreiro The pressure to get patents has never been greater for small and new companies. Patents are the hard currency of research-based businesses. Investors want to see them, competitors have them and companies need them for licensing, leveraging, litigating and (occasionally) liquidating.
|
|
February 21 2005
BC Biotech Announces Winners British Columbia's non-profit biotechnology industry association, BC Biotech (Vancouver, BC) has announced the recipients of its 2005 BC Biotechnology Awards.
|
|
February 08 2005
Shifting the Balance By Kristine Archer Biotechs are Levelling the Playing Field in Biopartnering
|
|
January 17 2005
Regulatory Gauges Of Success By Deborah Komlos Filing With the FDA at Top of Canadian Firms' To-Do Lists
|
|
November 12 2004
COMMUNICATE for Success By Michelle Floyd ANSWERING TWO CRITICAL QUESTIONS WILL ENSURE YOU COMMUNICATE MORE EFFECTIVELY
|
|
November 01 2004
Marriage of Big Business and Big Science By Vincent Wright Coveted Synergy Award Granted to TRIUMF-MDS Nordion Partnership
|
|
October 06 2004
Seed MONEY By Patricia Nicholson EARLY FUNDING FOR BIOTECH ENTREPRENEURS
|
|
October 04 2004
BHRC Study Highlights Industry Needs Early last week, the Biotechnology Human Resources Council (BHRC) (Ottawa, ON) released the results of its Converging Science and Leadership - The Key to the Future study, which focuses on initiatives needed to push innovation toward commercialization.
|
|
September 20 2004
The IPO window: who will follow MethylGene? By Patricia Nicholson The fourth quarter of 2003 and the first half of 2004 saw a surge in biotech IPOs in the United States, and led to speculation that the Canadian IPO window might be opening for the first time in several years. The biotech industry turned its eyes to MethylGene Inc. (Montreal, QC), which completed a much-anticipated initial public offering in June.
|
|
August 23 2004
BIG BIOTECHS AND SMALL STARTUPS By Patricia Nicholson ERNST & YOUNG'S ANNUAL BIOTECH REPORT SHOWS A GULF BETWEEN PROSPEROUS AND PRECARIOUS COMPANIES IN CANADA
|